Concurrent responses elicited by isolated activation of platelet Gq-coupled receptors, in vitro: A novel approach for their separation and analysis

Platelets

Volumn 14, Issue 2, 2003, Pages 89-102

  Maayani, Saul ^a   Patel, Nayana D ^a   Craddock Royal, Barbara D ^a   Schwarz, Todd E ^a   Tagliente, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; ARC 69931 MX; CELL RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; KETANSERIN; LEPIRUDIN; PHENTOLAMINE; PROPRANOLOL; PURINE P2 RECEPTOR; SEROTONIN; SEROTONIN 2A RECEPTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR;

ANALYSIS; ARTICLE; CELL AGGREGATION; CELL ISOLATION; CELL SEPARATION; CELL SHAPE; CELL STIMULATION; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; KINETICS; LIGHT SCATTERING; MEASUREMENT; NORMAL HUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TURBIDIMETRY;

AUTOCRINE COMMUNICATION; BLOOD PLATELETS; CELL SIZE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; KINETICS; MODELS, THEORETICAL; PLATELET ACTIVATION; PLATELET ADHESIVENESS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PURINERGIC P2; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;

EID: 0037364062     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953710031000080553     Document Type: Article

References (69)

1. Fukami M H, Holmse H, Kowalska M A, Niewiarowski S. Platelet secretion. In: Colman R W, Hirsh J, Marder V J, Clowes A W, George J N, eds. Hemostasis and Thrombosis; Basic Principles and Clinical Practice. Baltimore, MD: Lippincott/Williams & Wilkins, 2001: 561-73.
2. Woulfe D, Yang J, Prevost N, O'Brien P J, Brass L F. Signal transduction during the initiation, extension and perpetuation of platelet plug formation. In: Michelson A D, ed. Platelets. New York: Academic Press, 2002: 197-214.
3. Hoylaerts M F. Amplification loops: releases reaction. In: Gresele P, Clive P, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders. Cambridge: Cambridge University Press, 2002: 357-68.
4. Abrams C S, Brass L F. Platelet signal transduction. In: Colman R W, Hirsh J, Marder V J, Clows A W, George J N, eds. Hemostasis and Thrombosis; Basic Principles and Clinical Practice. Baltimore, MD: Lippincott/Williams & Wilkins, 2001: 541-59.
5. 2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000; 110: 925-34.
6. 2A receptors. J Biol Chem 1999; 274: 29108-14.
7. Jin J, Kunapuli S P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
8. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, Herbert J M. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 1998; 422: 291-5.
9. q protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation. FEBS Lett 1998; 435: 115-8.
10. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 1998; 103: 858-66.
11. Jantzen H-M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds E E, Conley P B. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost 1999; 81: 111-7.
12. 2T receptors. Br J Pharmacol 2000; 129: 275-82.
13. Maayani S, Tagliente T M, Schwarz T, Martinelli G, Martinez R, Shore-Lesserson L. The balance of concurrent aggregation and deaggregation processes in platelets is linked to differential occupancy of ADP receptor subtypes. Platelets 2001; 12: 83-93.
14. Maayani S, Tagliente T M, Schwarz T, Craddock-Royal B, Alcala C, Marrero G, Martinez R. Deaggregation is an integral component of the response of platelets to ADP in vitro: kinetic studies of literature and original data. Platelets 2001; 12: 279-91.
15. i-coupled receptors releases a tonic state of inhibited platelet aggregation. Platelets 2001; 12: 94-8.
16. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218: 284-94.
17. Yamamoto T, Egawa Y, Shirasawa Y, Ozaki Y, Sato K, Yatomi Y, Kume H. A laser light scattering in situ system for counting aggregates in blood platelet. Meas Sci Technol 1995; 6: 174-80.
18. Harrison P. Progress in the assessment of platelet function. Br J Haematol 2000; 111: 733-44.
19. Ryningen A, Holmsen H. Role of autocrine stimulation for the effects of cyclic AMP on protein and lipid phosphorylation in platelets activated by particles. FEBS Lett 1998; 436: 335-8.
20. Ryningen A, Jensen B O, Holmsen H. Role of autocrine stimulation on the effects of cyclic AMP on protein and lipid phosphorylation in collagen-activated and thrombin-activated platelets. Eur J Biochem 1999; 260: 87-96.
21. Selheim F, Idsoe R, Fukami M H, Holmsen H, Vassbotn F S. Formation of PI 3-kinase products in platelets by thrombin, but not collagen, is dependent on synergistic autocrine stimulation, particularly through secreted ADP. Biochem Biophys Res Commun 1999; 263: 780-5.
22. ADP-receptors. Br J Pharmacol 1998; 124: 157-64.
23. 1 receptor. Mol Pharmacol 1996; 50: 1323-9.
24. 2 receptor sites on human blood platelets. Biochem Pharmacol 1984; 33: 2807-11.
25. Anfossi G, Trovati M. Role of catecholamines in platelet function: Pathophysiological and clinical significance. Eur J Clin Invest 1996; 26: 353-70.
26. 2T receptor: a novel approach to antithrombotic therapy. J Med Chem 1999; 42: 213-20.
27. Eto K, Takeshita S, Ochiai M, Ozaki Y, Sato T, Isshiki T. Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability. Cardiovasc Res 1998; 40: 223-9.
28. Born G V, Hume M. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature 1967; 215: 1027-9.
29. Hause L L, Retzinger G S, Megan P A. A compartmental model of platelet aggregation in vitro: the kinetics of single platelets. Thromb Res 1989; 56: 133-46.
30. Wachsman D E, Kavaler J P, Sugar I P, Schachter E N, Gonsiorek W, Maayani S. Kinetic studies of desensitization and resensitization of the relaxation response to Beta-2 adrenoceptor agonists in isolated guinea pig trachea. J Pharmacol Exp Ther 1997; 280: 332-45.
31. i pathways in agonist-induced fibrinogen receptor activation. Biochem J 2002; 368: 535-43.
32. i signaling through the phosphoinositide-3 kinase pathway. Thromb Haemost 2001; 85: 341-8.
33. 2 receptors. Am J Physiol 1991; 260: H327-34.
34. 2A-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro. Platelets 2001; 12: 359-75.
35. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58-178.
36. Hallam T J, Scrutton M C, Wallis R B. Synergistic responses and receptor occupancy in rabbit blood platelets. Thromb Res 1982; 27: 435-45.
37. 1 receptor-null mice. J Clin Invest 1999; 104: 1731-7.
38. 1-deficient mice. Nat Med 1999; 5: 1199-202.
39. Ohlmann P, Eckly A, Freund M, Cazenave J-P, Offermanns S, Gachet C. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Gαq. Blood 2000; 96: 2134-9.
40. Fagura M S, Jarvis G E, Dougall I G, Leff P. Adventures in the pharmacological analysis of P2 receptors. J Auton Nerv Syst 2000; 81: 178-86.
41. Cory R N, Osman R, Maayani S. Kinetic characterization of the rabbit aorta contractile response to an alpha-adrenergic agonist. J Pharmacol Exp Ther 1984; 230: 162-70.
42. 2) receptor in the isolated rabbit aorta. J Pharmacol Exp Ther 1986; 236: 48-54.
43. 2 receptors in isolated rabbit aorta. J Pharmacol Exp Ther 1987; 242: 108-14.
44. Keitz S A, Osman R, Clarke W P, Goldfarb J, Maayani S. Functional interactions in smooth-muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta. J Pharmacol Exp Ther 1990; 255: 650-6.
45. Osman R, Keitz S A, Goldfarb J, Maayani S. Kinetics of response and drug-action. Neuropsychopharmacology 1990; 3: 417-25.
46. Ben-Harari R R, Dalton B A, Osman R, Maayani S. Kinetic characterization of 5-hydroxytryptamine receptor desensitization in isolated guinea-pig trachea and rabbit aorta. J Pharmacol Exp Ther 1991; 257: 416-24.
47. Wiener H L, Murray J M, Thalody G P, Maayani S. Kinetics of relaxation responses to vasorelaxants in isolated rabbit aorta. Eur J Pharmacol 1992; 220: 131-40.
48. Sugar I P, Paris G A, Martinelli G P, Gonsiorek W, Loza-Garcia M I, Tristan H, Maayani S. Kinetic studies of the concurrent desensitization and resensitization of the contractile response to 5-HT2B agonists in the isolated rat stomach fundus. Biophys J 1998; 74: A89-9.
49. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson E A, Cazenave J-P, Chap H, Gachet C. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 1999; 94: 4156-65.
50. 2 receptor activaion. Blood 2002; 100: 65b.
51. 2 receptor activation. Blood 2002; 100: 68b.
52. Bauer M, Retzer M, Wilde J I, Maschberger P, Essler M, Aepfelbacher M, Watson S P, Siess W. Dichotomous regulation of myosin phosphorylation and shape change by Rhokinase and calcium in intact human platelets. Blood 1999; 94: 1665-72.
53. Wilde J I, Retzer M, Siess W, Watson S P. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation. Platelets 2000; 11: 286-95.
54. 2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. J Biol Chem 1990; 265: 6836-44.
55. 2 mimetic, I-BOP. Adv Prostaglandin Thromboxane Leukot Res 1991; 21: 331-7.
56. 2 Receptors. J Lipid Mediators Cell Signal 1995; 12: 361-78.
57. 60 to Leu mutation. J Clin Invest 1996; 97: 949-56.
58. Habib A, FitzGerald G A, Maclouf J. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J Biol Chem 1999; 274: 2645-51.
59. 13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999; 144: 745-54.
60. q family. J Biol Chem 1991; 266: 9309-13.
61. Offermanns S, Laugwitz K L, Spicher K, Schultz G. G-Proteins of the G(12) family are activated via thromboxane a(2) and thrombin receptors in human platelets. Proc Natl Acad Sci USA 1994; 91: 504-8.
62. Offermanns S. The role of heterotrimeric G proteins in platelet activation. Biol Chem 2000; 381: 389-96.
63. Hall R A, Premont R T, Lefkowitz R J. Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol 1999; 145: 927-32.
64. Marinissen M J, Gutkind J S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001; 22: 368-76.
65. Milligan G, White J H. Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol Sci 2001; 22: 513-8.
66. Hashimoto Y, Togo M, Tsukamoto K, Horie Y, Watanabe T, Kurokawa K. Protein kinase C-dependent and -independent mechanisms of dense granule exocytosis by human platelets. Biochim Biophys Acta 1994; 1222: 56-62.
67. Hashimoto Y, Togo M, Sato H, Hashimoto N, Watanabe T, Kurokawa K, Nakahara K. Characteristics of protein kinase C-independent exocytosis in human platelets. Thromb Res 1997; 88: 51-8.
68. 2+-dependent mechanisms of secretion from streptolysin O-permeabilized platelets: effects of leakage of cytosolic proteins. Biochem J 1997; 328: 13-21.
69. 2+-independent secretion from platelets. Mol Biol Cell 1997 8 (suppl.): 2395.